1. Development of Rapid Through-put Nanotoxin Bioassays Perry Kanury Cassandra Viéville ~ Dr. Stacey Harper CBEE/EMT

2. Background: Nanomaterials are widely used in both industrial and consumer applications Currently thousands of distinct compounds in use, with more introduced every day o Found in every day products such as deodorant, sunscreen, Teflon, pesticides, etc. Little or no knowledge of the true environmental or molecular impacts of these materials o Distinct lack of methods or protocols for toxicity testing

3. What are nanomaterials?  Materials with at least one dimension between 1 and 100 nanometers o Planar: Single dimension in ‘nano’ scale  Example: Graphite sheet o Tubular: Two dimensions in ‘nano’ scale  Example: Bucky Tube o Globular: Three dimensions in ‘nano’ scale  Example: Bucky Ball

4. o Subcategory of nanomaterials  Formerly known as 'Ultra Fine Particles'  At least two dimensions between 1 and 100 nanometers in diameter, implying either tubular or globular shapes  Can take forms such as 'Nanoclusters', 'Nanocrystals', or 'Nanopowders' depending on agglomeration behavior  Wide range of applications including biomedical, optical and electronic fields  For reference: A typical nanoparticle has an effective diameter of approximately 1/800th that of a human hair. What are nanoparticles?  Often exhibit unique structure-property characteristics as a result of volume to surface area ratio and surface structure

5. What does this mean to us?  Wide range of possible effects to both human and ecological systems Examples:  Introduction of antimicrobial agents such as Aluminum Zirconium Tetrachlorohydrex (active ingredient in deodorant) into a town’s microbe-based water treatment system and subsequent watershed  Potential endocrine disruption (among additional myriad of effects) upon chronic exposure to Titanium Dioxide (active ingredient in many sunscreens) near lymph nodes, etc. o Possible disruption of ‘Lock and Key’ hormone identification mechanisms within the Endocrine system.

6. Need: Rapid testing strategies are necessary to identify specific nanomaterials that result in toxicity in order to mitigate risks from exposure and define structure-property relationships that can be used to predict nanomaterial fate and hazard in lieu of empirical data.

7. Hypothesis: An aquatic ecosystem can be modeled in the form of a ‘nanocosm’ ~ an extremely small tritrophic ecosystem (250 uL). Prediction: This ecosystem can be effectively used for the purpose of assessing the toxicity of nanoparticles in aquatic environments, as well as modeling the impacts of these nanoparticles on said ecosystems.

8. Another way of looking at it:

9. ‘Nano’ Algae Ciliate Bacteria Varying nanoparticle exposures (All 3 organisms)

10. o Tri-trophic aquatic ecosystem based upon our local temperate region  Photo-synthesizer (primary producer): Chlamydomonas reinhardtii (green algae)  Predator (primary consumer): Tetrahymena thermophilia (ciliate)  Decomposer (detritovore): E.coli (bacteria) o Suspended in a defined microbial media o Upon exposure by nanotoxins, can monitor population dynamics and predator/prey interactions to understand effects. Varying nanoparticle exposures The makeup and utilization of a Nanocosm: ‘Nano’ Algae Ciliate Bacteria (All 3 organisms)

11. Typical Plate Layout 0.01 ppm 0.05 ppm 0.1 ppm 0.5 ppm 1 ppm 5 ppm 10 ppm 50 ppm NanoBacteriaAlgaeCiliate Three replicates of each treatment for each organism Exposure Concentration

12. How we observe these interactions: Flow Cytometer Cell Concentration (cells/uL) of each organism are obtained and analyzed based upon effective size and fluorescence. Quantifies and categorizes cells via light diffraction and fluorescence. ‘Nano’ Algae Ciliate Bacteria (All 3 organisms) Varying nanoparticle exposures

13. How we observe these interactions: Tetrahymena Thermophilia AgNO 3 Exposure over 5 days

14. Treatment is observed relative to negative control within the same timepoint (((treatment-control)/control)*100) How we observe these interactions: Concentration Response

15. Future Work: Investigation of more ideal organisms than Tetrahymena thermophilia in order to streamline data collection utilizing existing equipment Investigation of additional endpoints beyond mortality Investigation of possible mechanisms of toxicity Establishment of a database of the effects of various nanotoxin exposures.

16. Acknowledgements: Dr. Stacey Harper Cassandra Viéville Howard Hughes Medical Institute Environmental Health Sciences Center (EHSC) Oregon State University Dr. Kevin Ahern